Efficacy of Sitagliptin When Added to Ongoing Therapy in Korean Subjects with Type 2 Diabetes Mellitus

BACKGROUND: To evaluate the clinical efficacy of sitagliptin for reducing plasma glucose levels in Korean subjects with type 2 diabetes mellitus during a 14-week treatment period. METHODS: Our study design involved the addition of 100 mg sitagliptin once-daily to three ongoing combination therapy re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hye Soo, Lee, Moon-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178703/
https://www.ncbi.nlm.nih.gov/pubmed/21977462
http://dx.doi.org/10.4093/dmj.2011.35.4.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178703/
https://www.ncbi.nlm.nih.gov/pubmed/21977462
http://dx.doi.org/10.4093/dmj.2011.35.4.411

Ejemplares similares